Skip to content

Small Airway Disease And Bronchial Hyperreactivity In Patients With Post Acute Covid-19 Syndrome

Small Airway Disease And Bronchial Hyperreactivity In Patients With Post Acute Covid-19 Syndrome

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06374420
Enrollment
100
Registered
2024-04-18
Start date
2021-09-01
Completion date
2024-04-01
Last updated
2024-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Brief summary

The aim of this work is to estimate the frequency of small airway disease and/or the bronchial hyperreactivity in follow up of postacute covid survivors.

Detailed description

This is a observational longitudinal study investigating pulmonary sequelae of covid-19. Study site: Mansoura university hospital, chest department and post covid outpatient clinic. Elmahalla chest hospital and outpatients clinic. Time of study : Two years from September 2021 to September 2023 Target population: Adults with confirmed covid 19 who remaining symptomatic after 30 days from the diagnosis. Sample size The study will include 100 selected cases during period from 2021 to 2023 Patients : The enrolled patients are adults who survived acute covid-19 and presented for clinical follow up.

Interventions

None listed

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Ambulatory adult patients confirmed diagnosis of covid -19 either on typical CT chest basis or PCR and passed period of acute illness (28 days from start of symptoms) but still with clinical symptoms.

Exclusion criteria

* Hospitalized or requiring intensive care unit. Known patients with chronic lung diseases Uncontrolled comorbidities

Design outcomes

Primary

MeasureTime frameDescription
investigating pulmonary sequelae of covid-19.3mothThe selected post covid patients on the day of their clinic visit (one to three months after being diagnosed covid 19

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026